Smart Inhalers - Global Market Outlook (2016-2022)

Smart Inhalers - Global Market Outlook (2016-2022)

  • Published: May 2017
  • ID: SMRC15986

According to Stratistics MRC, the Global Smart Inhalers market is accounted for $5.8 million in 2015 and is expected to reach $198 million by 2022 growing at a CAGR of 65.5% from 2015 to 2022. Increasing respiratory disorders, rise in air pollution, improved adherence to the inhaler are some of the factors boosting the market growth. However, lesser availability of smart inhalers, high expenditure of asthma and COPD treatment, and resistance towards adoption of smart inhalers are hindering the market growth. North America is projected to be the leading revenue generating region, whereas Asia-Pacific is projected to grow at the highest rate, due to rise in demand for smart inhalers and increase in COPD and asthma instances.

Some of the key players in global Smart Inhalers market are Propeller Health, Glenmark Pharmaceuticals, Qualcomm Life, Opko Health, Adherium Limited, GlaxoSmithKline plc, Novartis AG, AstraZeneca plc , Boehringer Ingelheim GmbH, 3M Drug Delivery Systems, Sensirion AG, Novartis AG, CoheroHealth, Crux Product Design Ltd, e-pill, LLC, Vectura Group plc, Teva Pharmaceutical Industries Ltd., OMRON Healthcare Europe B.V, Shenzhen Bi-Rich Medical Devices Co., Ltd, Inspiro Medical Ltd, TRI-MED, INC., PARI GmbH and Philips Respironics.

Products Covered:
• Inhalers
• Nebulizers
• Smater Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)

Disorders Covered:
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

End Users Covered:
• Patients
• Research & Development

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary      
        
2 Preface 
      
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Emerging markets     
 3.7 Product Analysis     
 3.8 End User Analysis     
        
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers       
 4.3 Threat of substitutes     
 4.4 Threat of new entrants        
 4.5 Competitive rivalry      
                              
5 Global Smart Inhalers Market, By Product   
 5.1 Introduction     
 5.2 Inhalers      
 5.3 Nebulizers     
 5.4 Smater Dry Powder Inhalers (DPIs)   
 5.5 Metered Dose Inhalers (MDIs)    
        
6 Global Smart Inhalers Market, By Disorder   
 6.1 Introduction     
 6.2 Asthma       
 6.3 Chronic Obstructive Pulmonary Disease (COPD)  
        
7 Global Smart Inhalers Market, By End User   
 7.1 Introduction     
 7.2 Patients       
 7.3 Research & Development    
        
8 Global Smart Inhalers Market, By Geography    
 8.1 North America     
  8.1.1 US     
  8.1.2 Canada     
  8.1.3 Mexico     
 8.2 Europe      
  8.2.1 Germany     
  8.2.2 France     
  8.2.3 Italy     
  8.2.4 UK     
  8.2.5 Spain     
  8.2.8 Rest of Europe    
 8.3 Asia Pacific     
  8.3.1 Japan     
  8.3.2 China     
  8.3.3 India     
  8.3.4 Australia     
  8.3.5 New Zealand    
  8.3.8 Rest of Asia Pacific    
 8.4 Rest of the World     
  8.4.1 Middle East    
  8.4.2 Brazil     
  8.4.3 Argentina    
  8.4.4 South Africa    
  8.4.5 Egypt     
        
9  Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 9.2 Acquisitions & Mergers         
 9.3 New Product Launch    
 9.4 Expansions          
 9.5 Other Key Strategies     
        
10 Company Profiling      
 10.1 Propeller Health     
 10.2 Glenmark Pharmaceuticals    
 10.3 Qualcomm Life     
 10.4 Opko Health     
 10.5 Adherium Limited     
 10.6 GlaxoSmithKline plc    
 10.7 Novartis AG     
 10.8 AstraZeneca plc     
 10.9 Boehringer Ingelheim GmbH    
 10.10 3M Drug Delivery Systems    
 10.11 Sensirion AG     
 10.12 Novartis AG     
 10.13 CoheroHealth     
 10.14 Crux Product Design Ltd    
 10.15 e-pill, LLC     
 10.16 Vectura Group plc     
 10.17 Teva Pharmaceutical Industries Ltd.   
 10.18 OMRON Healthcare Europe B.V   
 10.19 Shenzhen Bi-Rich Medical Devices Co., Ltd  
 10.20 Inspiro Medical Ltd     
 10.21 TRI-MED, INC.     
 10.22 PARI GmbH     
 10.23 Philips Respironics   


List of Tables                      
1 Global Smart Inhalers Market Analysis, by Region, (2013-2022) ($MN) 
2 Global Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN) 
3 Global Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN) 
4 Global Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
5 Global Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
6 Global Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
7 Global Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN) 
8 Global Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN) 
9 Global Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
10 Global Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN) 
11 Global Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN) 
12 Global Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
13 North America Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN)
14 North America Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
15 North America Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
16 North America Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
17 North America Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
18 North America Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
19 North America Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
20 North America Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
21 North America Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
22 North America Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
23 North America Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
24 North America Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
25 Europe Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN) 
26 Europe Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN) 
27 Europe Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN) 
28 Europe Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
29 Europe Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
30 Europe Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
31 Europe Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN) 
32 Europe Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN) 
33 Europe Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
34 Europe Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN) 
35 Europe Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN) 
36 Europe Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
37 Asia Pacific Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN)
38 Asia Pacific Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
39 Asia Pacific Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
40 Asia Pacific Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
41 Asia Pacific Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
42 Asia Pacific Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
43 Asia Pacific Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
44 Asia Pacific Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
45 Asia Pacific Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
46 Asia Pacific Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
47 Asia Pacific Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
48 Asia Pacific Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
49 RoW Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN) 
50 RoW Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN) 
51 RoW Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN) 
52 RoW Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN) 
53 RoW Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
54 RoW Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
55 RoW Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN) 
56 RoW Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN) 
57 RoW Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
58 RoW Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN) 
59 RoW Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN) 
60 RoW Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)

 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials